You have 9 free searches left this month | for more free features.

NHL

Showing 1 - 25 of 1,420

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

Recruiting
  • NHL
  • NHL, Relapsed, Adult
  • Birmingham, Alabama
  • +4 more
May 31, 2023

B-cell NHL, CLL Trial (CARCIK-CD19)

Not yet recruiting
  • B-cell NHL
  • CLL
  • CARCIK-CD19
  • (no location specified)
May 19, 2023

Hodgkin Lymphoma, B-Cell Lymphoma, Relapsed B-cell NHL Trial in Houston (Mosunetuzumab, Polatuzumab vedotin, Tafasitamab)

Not yet recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 7, 2022

Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • BTK inhibitor
  • PD-1 inhibitor
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
May 20, 2023

NHL, Adult, AML, Adult Recurrent Trial in Zhengzhou, Tianjin (ETH-155008)

Recruiting
  • NHL, Adult
  • AML, Adult Recurrent
  • Zhengzhou, Henan, China
  • +1 more
Feb 24, 2023

(CHANT)Real World Study of Duvelisib in Treatment of

Not yet recruiting
  • Follicular Lymphoma
  • +5 more
  • (no location specified)
Jun 20, 2023

Auto/Allo Tandem Transplant for Relapsed B-NHL

Completed
  • Non Hodgkin Lymphoma
  • auto transplant followed by allo transplant
  • (no location specified)
Oct 24, 2022

B-cell Non Hodgkin Lymphoma Trial in Xuzhou (regimen with BTK inhibitor +Anti-CD19 CAR T cells)

Recruiting
  • B-cell Non Hodgkin Lymphoma
  • regimen with BTK inhibitor +Anti-CD19 CAR T cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

CD20-positive Non-Hodgkin Lymphoma Trial in Seoul (Rituximab + MG4101)

Terminated
  • CD20-positive Non-Hodgkin Lymphoma
  • Rituximab + MG4101
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 24, 2022

Relapsed or Refractory Mantle Cell Lymphoma (MCL) Trial in Duarte (BAFFR-CAR T cells)

Recruiting
  • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
  • BAFFR-CAR T cells
  • Duarte, California
    City of Hope Medical Center
Oct 18, 2022

B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)

Recruiting
  • B-cell Non-Hodgkin Lymphoma (B-NHL)
  • UCART20x22
  • CLLS52
  • Austin, Texas
    Sarah Cannon - St. David South Austin Medical Center
Dec 8, 2022

SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • +2 more
    • (no location specified)
    Jun 22, 2023

    NK/T Cell Lymphoma, Vascular Immunomother T Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Guangzhou (GNC-038)

    Not yet recruiting
    • NK/T Cell Lymphoma
    • +2 more
    • Guangzhou, Guangdong, China
    • +1 more
    Jan 12, 2023

    Lymphoma, Non-Hodgkin, Lymphoma, T-Cell Trial in Najing (Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Lymphoma, T-Cell
    • Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection
    • Najing, Jiangsu, China
      Jiangsu Provincial People's Hospital
    Sep 26, 2022

    NHL Trial in Santa Monica (IGN002)

    Withdrawn
    • NHL
    • IGN002
    • Santa Monica, California
      UCLA
    Feb 23, 2022

    NHL, Leukemia Trial in Australia (ETH-155008)

    Recruiting
    • NHL
    • Leukemia
    • Adelaide, South Australia, Australia
    • +4 more
    Jun 8, 2022

    B Cell NHL, CLL Trial in Sydney, Melbourne, Mount Pleasant (GB261)

    Recruiting
    • B Cell NHL
    • CLL
    • GB261
    • Sydney, New South Wales, Australia
    • +4 more
    Nov 16, 2022

    Non-Hodgkin's Lymphoma Trial (MBS303)

    Not yet recruiting
    • Non-Hodgkin's Lymphoma
    • (no location specified)
    Apr 6, 2023

    LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

    Not yet recruiting
    • Relapsed Non-Hodgkin Lymphoma
      • (no location specified)
      Sep 19, 2023

      Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial (ONO-7018)

      Not yet recruiting
      • Lymphoma, Non-Hodgkin
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • (no location specified)
      Aug 23, 2022

      Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)

      Active, not recruiting
      • Non Hodgkin Lymphoma
      • UCD19 CAR T Cells
      • Aurora, Colorado
        University of Colorado Hospital
      Sep 1, 2022

      Non-Hodgkin Lymphoma Trial in Aurora (CD19x22 CAR T Cells)

      Active, not recruiting
      • Non-Hodgkin Lymphoma
      • CD19x22 CAR T Cells
      • Aurora, Colorado
        University of Colorado Hospital
      Sep 1, 2022

      B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

      Recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • B-cell Non Hodgkin Lymphoma
      • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
      • Aurora, Colorado
        Children's Hospital Colorado
      Nov 9, 2022

      NHL, Adult Trial in Zhengzhou, Shanghai, Nanyang (APG-1252, Chidamide)

      Recruiting
      • NHL, Adult
      • Zhengzhou, Henanan, China
      • +3 more
      Jul 27, 2022